Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy

British Journal of Cancer

Volumn 78, Issue 11, 1998, Pages 1495-1502

  Parsons, S L ^a   Watson, S A ^a   Collins, H M ^a   Griffin, N R ^a   Clarke, P A ^a   Steele, R J C ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Colorectal cancer; Gastric cancer; Gelatin zymography; Matrix metalloproteinase

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B;

ADENOMA; ARTICLE; COLORECTAL CANCER; COMPUTER PROGRAM; CONTROLLED STUDY; ENZYME ACTIVATION; GASTROINTESTINAL MUCOSA; GEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 0031740203     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.712     Document Type: Article

References (46)

1. Brown P, Levy A, Margulies I, Liotta L and Stetler-Stevenson W (1990) Independent expression and cellular processing of M(t) 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184-6191
2. Brown P, Bloxidge R, Stuart S, Gatter K and Carmichael J (1993a) Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Nl Cancer Ins 85: 574-578
3. Brown PD, Bloxidge RE, Anderson E and Howell A (1993b) Expression of activated gelatinase in human invasive breast carcinoma. Clin Expt Metastasis 11: 183-189
4. Chambers AF and Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Nl Cancer Inst 89: 1260-1270
5. Chandler S, Coates R, Gearing A, Lury J, Wells G and Bone E (1995) Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201: 223-226
6. Crabbe T, Smith B, JOC and Docherty A (1994) Human progelatinase A can be activated by matrilysin. FEBS Lett 345: 14-16.
7. David L, Nesland J, Holm R and Sobrinho-Simões M (1994) Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. Cancer 73: 518-527
8. Davies B, Miles D, Happerfield L, Naylor M, Bobrow L, Rubens R, and and Balkwill F (1993a) Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131
9. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F (1993b) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369.
10. Delaisse J-M and Vaes G (1992) Mechanism of mineral solubilisation and matrix degradation in osteoclastic bone resorption. In Biology and Physiology of the Osteoclast, FL, Rifkin BR and Gay CV (eds), pp 290-314, CRC Press: Boca Raton
11. D'Errico A, Garbisa S, Liotta L, Astronovo V, Stetler-Stevenson W and Grigioni W (1991) Augmentation of type IV collagenase, laminin receptor and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 4: 239-246
12. Gallegos NC, Smales C, Savage FJ, Hembry RM and Boulos PB (1995) The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol 4: 21-29
13. Grigioni WF, A, DE, Fortunato C, Fiorentino M, Mancini AM, Stetler-Stevenson WG, Sobel ME, Liotta LA, Onisto M and Garbisa S (1994) Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol 7: 220-225
14. Harris E (1990) Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322: 1277-1289
15. Heussen C and Dawdle E (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerised substrates. Anal Biochem 102: 196-202
16. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE and Turner DR (1991) Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 49: 666-672
17. Hibbs M, Hasty K, Seyer J, Kang AH and Mainardi CL (1985) Biochemical and immunological characterisation of the secreted forms of human neutrophil gelatinase. J Biol Chem 260: 2493-2500
18. Jass J, Love S and Northover J (1987) A new prognostic classification of rectal cancer. Lancet 1: 1303-1306
19. Jeffrey J (1991) Collagen and collagenase: pregnancy and parturition. Semin Perinatol 15: 118-126
20. Kleiner D and Stetler-Stevenson W (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329
21. Liabakk N, Talbot I, Smith RA, Wilkinson K and Balkwill F (1996) Matrix metalloproteinases 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56: 190-196
22. Liotta LA and Stetler-Stevenson WG (1990) Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99-106
23. Matrisian L (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125
24. Matrisian LM (1994) Matrix metalloproteinase gene expression. Ann N Y Acad Sci 732: 42-50
25. Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio MC, Eber M and Methlin G (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 53: 165-169
26. Murray G, Duncan M, O'Neil P, Melvin W and Fothergill J (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med 2: 461-462
27. Naylor MS, Stamp GW, Davies BD and Balkwill FR (1994) Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58: 50-56
28. Newell KJ, Witty JP, Rodgers WH and Matrisian LM (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinogen 10: 199-206
29. Nomura H, Sato H, Seiki M, Mai M and Okada Y (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266
30. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K and Hayakawa T (1992) Matrix metalloproteinase 9 (92-kDa gelatinase / type IV collagenase) from HT1080 human fibrosarcoma cells. J Biol Chem 267: 21712-21719
31. Page RC (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 26: 230-242
32. Parsons SL, Watson S, Griffin N and Steele R (1996) An open phase I/II study of the oral matrix metalloproteinase inhibitor, marimastat in patients with inoperable gastric cancer (abstract), Ann Oncol 7: 47
33. Parsons SL, Watson S, Brown P, Collins H and Steele R (1997) Matrix metalloproteinases. Br J Surg 84: 160-166
34. Pyke C, Ralfkiaer E, Tryggvason K and Dano K (1993) Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359-364
35. Sang QX, Birkedal-Hansen H and Van Wart HE (1995) Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta 1251: 99-108
36. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65
37. Satoh K, Ohtani H, Shimosegawa T, Koizumi M, Sawai T and Toyota T (1994) Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gastroenterology 107: 1488-1495
38. Sier C, Kubben F, Ganesh S, Heerding MM, Griffoen G, Hanemaaijer R, van Krieken JHJM, Lamers CBHW and Verspaget HW (1996) Tissue levels of MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74: 413-417
39. Suzuki K, Enghild JJ, Morodomi T, Salvesen G and Nagase H (1990) Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261-10270
40. Talhouk R, Bissel M and Werb Z (1992) Co-ordinated expression of extracellular matrix degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118: 1271-1282
41. Wilson MJ and Sinha AA (1993) Plasminogen activator and metalloprotease activities of Du-145, PC-3, and I-LN-PC-3-1A human prostate tumors grown in nude mice: correlation with tumor invasive behavior. Cell Mol Biol Res 39: 751-760
42. Woessner JF, Jr (1995) Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 248: 510-528
43. Wolf C, Chenard MP, Durand de Grossouvre P, Bellocq JP, Chambon P and Basset P (1992) Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol 99: 870-872
44. Wysocki AB, Staiano-Coico I, and Grinnell F (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101: 64-68
45. Yamagata S, Yoshii Y, Suh JG, Tanaka R and Shimizu S (1991) Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett 59: 51-55
46. Zeng ZS and Guillem JG (1995) Distinct patient of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 72: 575-582